Selank (Anxiolytic Heptapeptide)
Category: Cognitive & Neurological
Selank is a synthetic analog of the naturally occurring immunomodulatory peptide tuftsin, with an additional sequence that provides enhanced stability and neurological activity. Like Semax, it was developed at the Institute of Molecular Genetics in Russia and has been approved as a prescription medication in Russia for anxiety and related disorders.
This guide compiles key literature themes, handling context, and practical comparison points for research-focused evaluation.
By Maylene · Page updated
Overview
The peptide's mechanism centers on GABA system modulation, producing anxiolytic effects that researchers have compared to benzodiazepines but without the sedation, cognitive impairment, or dependence potential. This clean anxiolytic profile has generated significant research interest internationally.
Discovery & Background
Selank was developed through the 1990s and 2000s by researchers at the Russian Academy of Sciences, building on earlier work with the immunopeptide tuftsin. The goal was to create a compound with anxiolytic properties that lacked the drawbacks of existing medications. After extensive preclinical work, it received regulatory approval in Russia and has been available as a nasal spray since the early 2010s.
Mechanism of Action
Selank modulates the GABAergic system and influences serotonin metabolism, producing anxiolytic effects without sedation or dependency. It also has immunomodulatory properties inherited from its tuftsin parent molecule.
- 1Modulates GABA receptor activity, enhancing inhibitory signaling in anxiety-related circuits
- 2Increases BDNF expression, though to a lesser degree than Semax
- 3Influences serotonin metabolism and 5-HT receptor sensitivity
- 4Stabilizes enkephalin degradation, prolonging the activity of natural anti-anxiety peptides
- 5Retains immunomodulatory properties from its tuftsin base, influencing cytokine balance
- 6Does not produce tolerance, dependence, or withdrawal in published studies
Research Benefits
The benefit areas below reflect commonly discussed research interests for this peptide.
Anxiolytic Effects
Reduces anxiety-like behavior in animal models with potency comparable to benzodiazepines, but without sedation or dependency.
Cognitive Support
Studies show improvements in learning and memory alongside anxiety reduction, a combination not typical of traditional anxiolytics.
Immunomodulation
Modulates immune function through its tuftsin-derived structure, potentially useful in psychoneuroimmunology research.
No Dependency
Published research shows no tolerance development, physical dependence, or withdrawal effects with sustained use.
Reported Side Effects & Considerations
- •Well-tolerated in published clinical use data
- •Mild nasal irritation with intranasal administration
- •No sedation reported in published studies
- •No tolerance or dependence observed in chronic administration studies
Storage Background: Freeze-Dried Vials
General background for lyophilised (freeze-dried) research peptides supplied as powder in vials. A prefilled pen is a different format: store it as its own label and product documentation state.
Temperature
2-8C refrigerated
Once Reconstituted
Use within 14 days when refrigerated
Shelf Life
24 months lyophilized at -20C
Frequently Asked Questions
What is Selank?
Selank is a synthetic heptapeptide based on the natural immunopeptide tuftsin with an added Pro-Gly-Pro sequence. It was developed in Russia as an anxiolytic without the drawbacks of benzodiazepines.
How does Selank reduce anxiety?
Selank modulates the GABA system and stabilizes enkephalins, the body's natural anti-anxiety peptides. Unlike benzodiazepines, it does not cause sedation, cognitive impairment, or physical dependence.
Can Selank and Semax be studied together?
Yes. Some researchers study them in combination because they have complementary mechanisms. Semax primarily enhances cognition through BDNF, while Selank targets anxiety through GABA modulation.
What is tuftsin?
Tuftsin is a naturally occurring tetrapeptide (Thr-Lys-Pro-Arg) involved in immune function. It stimulates phagocytosis and immune cell activity. Selank was built on the tuftsin backbone with additional amino acids.
How is Selank administered in research?
Like Semax, Selank is typically administered intranasally in published studies. This route provides rapid absorption and good bioavailability for CNS research.
Sources & evidence
These papers describe the stated compounds and study models. They do not test or certify Maylene products. Animal or cell findings do not establish human benefit, and pharmaceutical trials do not validate research-only pens.
- Selank and phenazepam comparison — Medvedev et al., 2014
Comparative clinical study of 60 patients. The abstract does not establish long-term safety or equivalence to all anxiety treatments.
Research Disclaimer
This guide is for educational and informational purposes only. All information is based on published scientific research and peer-reviewed literature. Peptides sold by Maylene are intended solely for laboratory research use and are not for human consumption. Consult healthcare professionals before making any health decisions.
The catalogue
There is no Selank product in the current catalogue. This guide is background reading.
Browse All PeptidesRelated Peptide Guides
Explore More Peptide Guides
Explore adjacent compounds to compare mechanisms, side-effect discussions, and study focus across related peptides.
Start Your Research Today
Compare current listings, labelled content and product documentation before ordering.
Products from Maylene are supplied strictly for laboratory and scientific research use only.
Shop Peptides